120 related articles for article (PubMed ID: 1661058)
21. The significance of extracellular mucin in breast fine needle aspiration specimens.
Shield PW; Ribu DL; Cominos D
Cytopathology; 2016 Jun; 27(3):185-92. PubMed ID: 26104545
[TBL] [Abstract][Full Text] [Related]
22. Mean nuclear area and metallothionein expression in ductal breast tumors: correlation with estrogen receptor status.
El Sharkawy SL; Farrag AR
Appl Immunohistochem Mol Morphol; 2008 Mar; 16(2):108-12. PubMed ID: 18227734
[TBL] [Abstract][Full Text] [Related]
23. Quantitative study of breast cancer progression: different pathways for various in situ cancers.
Mariuzzi L; Mombello A; Granchelli G; Rucco V; Tarocco E; Frank D; Davis J; Thompson D; Bartels H; Mariuzzi GM; Bartels PH
Mod Pathol; 2002 Jan; 15(1):18-25. PubMed ID: 11796837
[TBL] [Abstract][Full Text] [Related]
24. Needle cytology of the breast. A quantitative and qualitative study of the cells of benign and malignant ductal neoplasia.
Dziura BR; Bonfiglio TA
Acta Cytol; 1979; 23(4):332-40. PubMed ID: 231367
[TBL] [Abstract][Full Text] [Related]
25. Diffusion-weighted imaging (b value = 1500 s/mm(2)) is useful to decrease false-positive breast cancer cases due to fibrocystic changes.
Ochi M; Kuroiwa T; Sunami S; Murakami J; Miyahara S; Nagaie T; Oya M; Yabuuchi H; Hatakenaka M
Breast Cancer; 2013 Apr; 20(2):137-44. PubMed ID: 22161277
[TBL] [Abstract][Full Text] [Related]
26. Invasive cystic hypersecretory carcinoma of the breast: a rare variant of breast cancer: a case report and review of the literature.
Sun J; Wang X; Wang C
BMC Cancer; 2019 Jan; 19(1):31. PubMed ID: 30621638
[TBL] [Abstract][Full Text] [Related]
27. Standardized in situ AgNOR analysis in breast pathology: diagnostic and cell kinetic implications.
Bànkfalvi A; Ofner D; Schmid KW; Schmitz KJ; Breukelmann D; Krech R; Böcker W
Pathol Res Pract; 1999; 195(4):219-29. PubMed ID: 10337659
[TBL] [Abstract][Full Text] [Related]
28. Computational pathology to discriminate benign from malignant intraductal proliferations of the breast.
Dong F; Irshad H; Oh EY; Lerwill MF; Brachtel EF; Jones NC; Knoblauch NW; Montaser-Kouhsari L; Johnson NB; Rao LK; Faulkner-Jones B; Wilbur DC; Schnitt SJ; Beck AH
PLoS One; 2014; 9(12):e114885. PubMed ID: 25490766
[TBL] [Abstract][Full Text] [Related]
29. Expression of c-kit in common benign and malignant breast lesions.
Kondi-Pafiti A; Arkadopoulos N; Gennatas C; Michalaki V; Frangou-Plegmenou M; Chatzipantelis P
Tumori; 2010; 96(6):978-84. PubMed ID: 21388062
[TBL] [Abstract][Full Text] [Related]
30. Quantitative study of ductal breast cancer progression: nuclear signatures for evaluation of progression grade.
Mombello A; Mariuzzi L; Morelli L; Granchelli G; Rucco V; Tarocco E; da Silva VD; Thompson D; Bartels HG; Bartels PH; Mariuzzi G
Adv Clin Path; 2001 Jul; 5(3):59-70. PubMed ID: 11753877
[TBL] [Abstract][Full Text] [Related]
31. Semiquantitative analyses of fine needle aspirates from benign and malignant breast lesions.
Thomas JS; Mallon EA; George WD
J Clin Pathol; 1989 Jan; 42(1):28-34. PubMed ID: 2537853
[TBL] [Abstract][Full Text] [Related]
32. Fine-needle aspiration of breast biopsy specimens: correlation of histologic and cytologic findings.
Teixidor HS; Wojtasek DA; Reiches EM; Santos-Buch CA; Minick CR
Radiology; 1992 Jul; 184(1):55-8. PubMed ID: 1319077
[TBL] [Abstract][Full Text] [Related]
33. [The diagnostic value of 34 betaE 12 in differential diagnosis of benign and malignant mammary lesions].
Di F; Wong NL
Zhonghua Bing Li Xue Za Zhi; 2004 Feb; 33(1):31-5. PubMed ID: 14989925
[TBL] [Abstract][Full Text] [Related]
34. Argyrophilic nucleolar organiser regions (AgNORs) in breast lesions.
Dasgupta A; Ghosh RN; Sarkar R; Laha RN; Ghosh TK; Mukherjee C
J Indian Med Assoc; 1997 Sep; 95(9):492-4. PubMed ID: 9529579
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic accuracy of fiberoptic ductoscopy plus in vivo iodine staining for intraductal proliferative lesions.
Feng XZ; Song YH; Zhang FX; Jiang CW; Mei H; Zhao B
Chin Med J (Engl); 2013 Aug; 126(16):3124-9. PubMed ID: 23981624
[TBL] [Abstract][Full Text] [Related]
36. [Clinicopathologic and immunohistochemical study of 187 cases of intraductal papillary neoplasm of breast].
Zhang H; Xiong Y; Zhang S; Zhang Y; Wang YH; Li T
Zhonghua Bing Li Xue Za Zhi; 2011 Nov; 40(11):726-31. PubMed ID: 22336153
[TBL] [Abstract][Full Text] [Related]
37. Immunocytochemical analysis of p63 and 34βE12 in fine needle aspiration cytology specimens for breast lesions: a potentially useful discriminatory marker between intraductal papilloma and ductal carcinoma in situ.
Hoshikawa S; Sano T; Hirato J; Oyama T; Fukuda T
Cytopathology; 2016 Apr; 27(2):108-14. PubMed ID: 25810244
[TBL] [Abstract][Full Text] [Related]
38. Fast 3D Near-infrared breast imaging using indocyanine green for detection and characterization of breast lesions.
Schneider P; Piper S; Schmitz CH; Schreiter NF; Volkwein N; Lüdemann L; Malzahn U; Poellinger A
Rofo; 2011 Oct; 183(10):956-63. PubMed ID: 21972043
[TBL] [Abstract][Full Text] [Related]
39. [Analysis of the clinicopathological characteristics and prognosis in 674 cases of breast intraductal papillary tumor].
Wang WY; Wang X; Gao JD; Wang J; Liu JQ; Wang X; Zhao DB
Zhonghua Zhong Liu Za Zhi; 2017 Jun; 39(6):429-433. PubMed ID: 28635232
[No Abstract] [Full Text] [Related]
40. Mucinous lesions of the breast. A pathological continuum.
Weaver MG; Abdul-Karim FW; al-Kaisi N
Pathol Res Pract; 1993 Sep; 189(8):873-6. PubMed ID: 8302709
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
